PROTOCOL NIDA-CTN-0055


Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES)

Todd Korthuis, MD, MPH
Oregon Heath & Science University
korthuis@ohsu.edu

HIV-infected patients receiving office-based treatment are more likely to achieve HIV viral suppression, decreasing the overall community viral load and associated HIV incidence. Injection drug users are least likely to engage in HIV care and achieve HIV viral suppression compared to other HIV risk groups. Substance abuse treatment can increase engagement in HIV care, but HIV providers have limited options for long-acting office-based addiction treatments. This study will compare extended-release naltrexone to treatment as usual for opioid dependence in approximately 400 HIV-infected patients.

RELATED RESOURCES

snowflake

Publications about CTN-0055

ClinicalTrials.gov (NCT01908062)

NIDA protocol page


NODES & CTPs SEARCH LINK
Western States (Lead) search www
University of British Columbia search
Ohio Valley search www
The CORE Center search

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 6/2012 -- http://ctndisseminationlibrary.org/protocols/ctn0055.htm
info@ctndisseminationlibrary.org